Suppr超能文献

经皮血管内动脉瘤修复首次入路引入后的单中心经验

Single-Center Experience Following the Introduction of a Percutaneous Endovascular Aneurysm Repair First Approach.

作者信息

Ashrafi Mohammed, Al-Jarrah Qusai, Anandarajah Mayooreshan, Ashleigh Ray, Welch Mark, Baguneid Mohamed

机构信息

1 Department of Vascular and Endovascular Surgery, University Hospital of South Manchester, Manchester, United Kingdom.

出版信息

Angiology. 2017 Feb;68(2):119-123. doi: 10.1177/0003319716646681. Epub 2016 Jul 11.

Abstract

We evaluated our experience following the introduction of a percutaneous endovascular aneurysm repair (pEVAR) first approach using Perclose Proglide assessing efficacy, complications, and identification of factors that could predict failure. A retrospective cohort study on patients over a 2-year period following the introduction of a pEVAR first approach was performed. The primary end point was defined as successful deployment and access site hemostasis. Percutaneous EVAR was technically successful in 41 (77.4%) of 53 patients and 83 (86.5%) of 96 access sites. Factors associated with failure were smaller common femoral artery (CFA) diameter ( P = .045) and CFA circumferential calcification of greater than 50% ( P = .0001). The incidence of access site infection was significantly higher in the failure group ( P = .008) as was procedure duration ( P = .026). Percutaneous EVAR first approach must be introduced with caution. Percutaneous EVAR failure occurs more often in patients with unfavorable access site anatomy. Success rate can be improved with careful patient selection.

摘要

我们评估了采用Perclose Proglide经皮血管腔内动脉瘤修复术(pEVAR)优先入路后的经验,评估其疗效、并发症以及确定可预测失败的因素。对采用pEVAR优先入路后2年内的患者进行了一项回顾性队列研究。主要终点定义为成功植入和穿刺部位止血。53例患者中有41例(77.4%)、96个穿刺部位中有83个(86.5%)经皮血管腔内动脉瘤修复术在技术上取得成功。与失败相关的因素包括股总动脉(CFA)直径较小(P = 0.045)以及CFA周向钙化大于50%(P = 0.0001)。失败组穿刺部位感染的发生率显著更高(P = 0.008),手术时间也更长(P = 0.026)。必须谨慎采用经皮血管腔内动脉瘤修复术优先入路。经皮血管腔内动脉瘤修复术失败在穿刺部位解剖结构不利的患者中更常发生。通过仔细选择患者可提高成功率。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验